Marcel Doerflinger
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- Molecular Biology top 10%
- Cell death mechanisms and regulation
- Inflammasome and immune disorders
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- Tuberculosis Research and Epidemiology 3
- COVID-19 Clinical Research Studies 3
-
- Cell death mechanisms and regulation 17
- Inflammasome and immune disorders 4
- Co-authors
- Marc Pellegrini (20 shared papers)Hamsa Puthalakath (12 shared papers)Marco J. Herold (8 shared papers)Michael D. Stutz (3 shared papers)Stefanie M. Bader (6 shared papers)James P. Cooney (6 shared papers)Cody C. Allison (10 shared papers)Michelle P. Clark (3 shared papers)
- Journals
- Nature Communications (6 papers)Cell Death and Disease (5 papers)Cell Death and Differentiation (5 papers)Clinical & Translational Immunology (3 papers)Immunity (3 papers)
- Partner nations
- AustraliaGermanyUnited States
In The Last Decade
Marcel Doerflinger
52 papers receiving 1.9k citations
Marcel Doerflinger's Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 568
- Molecular Biology 691
- Immunology 182
- Computational Theory and Mathematics 122
- Virology 26
Countries citing papers authored by Marcel Doerflinger
This map shows the geographic impact of Marcel Doerflinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Doerflinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Doerflinger more than expected).
Fields of papers citing papers by Marcel Doerflinger
This network shows the impact of papers produced by Marcel Doerflinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Doerflinger. The network helps show where Marcel Doerflinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcel Doerflinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 405 | |
| 2 | 2020 | 122 | |
| 3 | 2022 | 112 | |
| 4 | 2021 | 110 | |
| 5 | 2021 | 78 | |
| 6 | 2015 | 72 | |
| 7 | 2017 | 67 | |
| 8 | 2016 | 62 | |
| 9 | 2023 | 59 | |
| 10 | 2020 | 58 | |
| 11 | 2017 | 55 | |
| 12 | 2022 | 55 | |
| 13 | 2016 | 52 | |
| 14 | 2022 | 46 | |
| 15 | 2019 | 43 | |
| 16 | 2013 | 40 | |
| 17 | 2015 | 39 | |
| 18 | 2019 | 34 | |
| 19 | 2022 | 30 | |
| 20 | 2020 | 27 |
About Marcel Doerflinger
Marcel Doerflinger is a scholar working on Infectious Diseases, Molecular Biology, Immunology, Epidemiology and Virology, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (17 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Sepsis Diagnosis and Treatment (4 papers), Inflammasome and immune disorders (4 papers), T-cell and B-cell Immunology (3 papers), Tuberculosis Research and Epidemiology (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (568 citations), Molecular Biology (691 citations), Immunology (182 citations), Computational Theory and Mathematics (122 citations) and Virology (26 citations). Marcel Doerflinger has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Marc Pellegrini, Hamsa Puthalakath, Marco J. Herold, Michael D. Stutz, Stefanie M. Bader, James P. Cooney, Cody C. Allison, Michelle P. Clark, Gregor Ebert and Philip Arandjelovic. Their work appears in journals such as Nature Communications, Cell Death and Disease, Cell Death and Differentiation, Clinical & Translational Immunology and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.